Alphatec vs Glaukos
ATEC and GKOS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ATEC and GKOS compare
Glaukos is the larger company, worth 13 times as much as Alphatec ($14.5B against $1.1B).
Glaukos grew revenue faster over the last twelve months (46.9% versus 15.3% for Alphatec).
Alphatec keeps more of each dollar of sales as profit, with a net margin of −10.3% compared with −24.6% at Glaukos.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ATEC | GKOS |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $14.5B |
| Share price | $7.07 | $245.72 |
| Change, 1 year | −65.9% | 165% |
| Change, 5 years | −37.3% | 411% |
| Beta (5Y) | 1.16 | 1.02 |
| Employees | 913 | 1,094 |
| StockData Score | ||
| Total score | 7 | 7 |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 | 3 |
| Performance score | 2 | 2 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× (better) | 21.1× |
| P/B | – | 20.3× |
| EV/EBITDA | 40.1× | – |
| P/FCF | 358× (better) | 404× |
| FCF yield | 0.28% (better) | 0.25% |
| Fair value | – | $77.09 |
| Margin of safety | – | −219% |
| Growth | ||
| Revenue growth (TTM) | 15.3% | 46.9% (better) |
| Revenue growth, 5Y average | 39.5% (better) | 17.7% |
| Profitability | ||
| Gross margin | 71.3% (better) | 64.8% |
| Operating margin | −3.6% (better) | −25.5% |
| Net margin | −10.3% (better) | −24.6% |
| FCF margin | 0.37% | 5.2% (better) |
| Return on equity | −1888% | −22.8% (better) |
| Return on invested capital | −5.0% (better) | −22.8% |
| Financial health | ||
| Net debt / EBITDA | 12.06 | – |
| Interest coverage | −0.7× (better) | −36.6× |
| Current ratio | 2.36 | 4.57 (better) |
| Altman Z-score | −0.49 | 32.56 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 72.7% | 103% |
| Held by insiders | 23.5% | 5.3% |
| Insider net buying, 12 months | −$40.9M (better) | −$78.8M |
| Short interest, % of float | 12.0% | 8.0% |
Go deeper
- ATEC stock overview
- ATEC income statement
- ATEC valuation and score
- GKOS stock overview
- GKOS income statement
- GKOS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.